[1] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71: 209-249. [2] Goldstraw P, Chansky K, Crowley J, et al.The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer[J]. J Thorac Oncol, 2016, 11(1): 39-51. [3] Ettinger DS, Akerley W, Borghaei H, et al.Non-small cell lung cancer, version 2.2013[J]. J Natl Compr Canc Netw, 2013, 11(6): 645-653. [4] St Laurent G, Wahlestedt C, Kapranov P.The Landscape of long noncoding RNA classification[J]. Trends Genet, 2015, 31(5): 239-251. [5] Lee YS, Dutta A.MicroRNAs in cancer[J]. Annu Rev Pathol, 2009, 4: 199-227. [6] Çalışkan M, Güler H, Bozok Çetintaş V.Current updates on microRNAs as regulators of chemoresistance[J]. Biomed Pharmacother, 2017, 95: 1000-1012. [7] Li Y, Wang Y, Fan H, et al.miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522[J]. Biochem Biophys Res Commun, 2018, 504(1): 277-282. [8] Hua S, Quan Y, Zhan M, et al.miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1[J]. Cancer Cell Int, 2019, 19: 203. [9] Liu S, Chen Q, Wang Y.MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway[J]. Hum Cell, 2020, 33(1): 185-194. [10] Jin FE, Xie B, Xian HZ, et al.Knockdown of miR-125b-5p inhibits the proliferation and invasion of gastric carcinoma cells by targeting RYBP[J]. Kaohsiung J Med Sci, 2021, 37(10): 863-871. [11] Wang M, Zhu X, Sha Z, et al.High expression of kinesin light chain-2, a novel target of miR-125b, is associated with poor clinical outcome of elderly non-small-cell lung cancer patients[J]. Br J Cancer, 2015, 112(5): 874-882. [12] Shi H, Li K, Feng J, et al.LncRNA-DANCR Interferes With miR-125b-5p/HK2 Axis to Desensitize Colon Cancer Cells to Cisplatin vis Activating Anaerobic Glycolysis[J]. Front Oncol, 2020, 10: 1034. [13] Deng P, Sun M, Zhao WY, et al.Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis[J]. World J Gastroenterol, 2021, 27(6): 487-500. [14] Yang D, Zhan M, Chen T, et al.miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer[J]. Sci Rep, 2017, 7: 43109. [15] Fujita Y, Yagishita S, Hagiwara K, et al.The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer[J]. Mol Ther, 2015, 23(4): 717-727. [16] Chen KB, Yang W, Xuan Y, et al.miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1[J]. Cell Death Dis, 2021, 12(8): 748. [17] Hossian AKMN, Zahra FT, Poudel S, et al.Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance[J]. Sci Rep, 2021, 11(1): 6520. [18] Zhang Y, Huang S.Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells[J]. Biol Chem, 2015,15. [19] 倪耀军,徐忠能,陈胜,等. 非小细胞肺癌细胞A549顺铂耐药潜在机制的全转录组测序分析[J]. 中国胸心血管外科临床杂志,2021,28(1):35-42. [20] CHAN JJ, TAY Y.Noncoding RNA: RNA regulatory networks in cancer[J]. Int J Mol Sci, 2018, 19(5): 1310. [21] Hong L, Yang Z, Ma J, et al.Function of miRNA in controlling drug resistance of human cancers[J]. Curr Drug Targets, 2013, 14(10): 1118-1127. [22] Méndez O, Zavadil J, Esencay M, et al.Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres[J]. Mol Cancer, 2010, 9(1): 133. [23] Zhang Z, Tang Y, Song X, et al.Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer[J]. Front Oncol, 2020, 10: 560025. |